Sanofi has moved to bolster its vaccines business by reaching a deal to buy London, UK-based biotech Vicebio, which was formed to produce improved, more potent shots that are simpler to manufacture.

Amazon (AMZN.O), opens new tab is considering an investment of around $10 billion in OpenAI, though talks remain "very fluid," according to a source who requested anonymity due to the private nature ...